Market overview
The global animal immunoassay kits market is worth USD 1.5 bn in 2026 and is forecast to reach USD 2.9 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Rapid lateral flow and in-clinic is the largest by technique segment.
| Scope | Enzyme and lateral-flow immunoassay test kits used to detect disease, pregnancy and residues in companion animals and livestock, sold to veterinary clinics, laboratories and farms. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.4 bn |
| Value 2026 | USD 1.5 bn |
| Value 2036 | USD 2.9 bn |
| CAGR 2026-2036 | 7.0% |
| Volume 2026 | 117 million tests |
| Volume 2036 | 208 million tests |
| Average price 2026 | USD 12.8 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Animal Immunoassay Kits market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.5 bn |
| 2027 | USD 1.6 bn |
| 2028 | USD 1.7 bn |
| 2029 | USD 1.8 bn |
| 2030 | USD 2.0 bn |
| 2031 | USD 2.1 bn |
| 2032 | USD 2.2 bn |
| 2033 | USD 2.4 bn |
| 2034 | USD 2.6 bn |
| 2035 | USD 2.8 bn |
| 2036 | USD 2.9 bn |
Animal Immunoassay Kits market segmentation
By technique
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rapid lateral flow and in-clinic | 48.0% | 49.8% | USD 719 mn | 7.4% |
| ELISA kits | 38.0% | 34.3% | USD 569 mn | 5.9% |
| Other immunoassays | 14.0% | 15.9% | USD 210 mn | 8.4% |
By animal
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Companion animals | 58.0% | 62.9% | USD 869 mn | 7.9% |
| Cattle and dairy | 16.0% | 14.4% | USD 240 mn | 5.9% |
| Swine and poultry | 18.0% | 15.5% | USD 270 mn | 5.4% |
| Other animals | 8.0% | 7.2% | USD 120 mn | 5.9% |
By target
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Infectious disease | 46.0% | 44.0% | USD 689 mn | 6.5% |
| Pregnancy and fertility | 22.0% | 22.0% | USD 330 mn | 7.0% |
| Residues and toxins | 18.0% | 20.0% | USD 270 mn | 8.1% |
| Endocrine and metabolic | 14.0% | 14.0% | USD 210 mn | 7.0% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Veterinary clinics | 42.0% | 42.0% | USD 629 mn | 7.0% |
| Reference laboratories | 28.0% | 27.0% | USD 419 mn | 6.6% |
| Farms and producers | 18.0% | 18.0% | USD 270 mn | 7.0% |
| Food testing and research | 12.0% | 13.0% | USD 180 mn | 7.9% |
By sample type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Blood and serum | 52.0% | 50.0% | USD 779 mn | 6.6% |
| Milk | 18.0% | 18.0% | USD 270 mn | 7.0% |
| Faeces and swabs | 18.0% | 19.0% | USD 270 mn | 7.6% |
| Tissue and other samples | 12.0% | 13.0% | USD 180 mn | 7.9% |
Top 25 countries for animal immunoassay kits by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.5% of 2026 revenue and the 25 countries below together hold 96.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 539 mn | 36.0% | USD 1.0 bn | 6.6% |
| 2 | China | USD 165 mn | 11.0% | USD 413 mn | 9.6% |
| 3 | Germany | USD 90 mn | 6.0% | USD 162 mn | 6.1% |
| 4 | France | USD 75 mn | 5.0% | USD 136 mn | 6.1% |
| 5 | Brazil | USD 75 mn | 5.0% | USD 162 mn | 8.0% |
| 6 | Japan | USD 75 mn | 5.0% | USD 141 mn | 6.6% |
| 7 | United Kingdom | USD 75 mn | 5.0% | USD 136 mn | 6.1% |
| 8 | Italy | USD 52 mn | 3.5% | USD 94 mn | 6.0% |
| 9 | Canada | USD 45 mn | 3.0% | USD 85 mn | 6.6% |
| 10 | Spain | USD 45 mn | 3.0% | USD 80 mn | 5.9% |
| 11 | Netherlands | USD 21 mn | 1.4% | USD 39 mn | 6.1% |
| 12 | Australia | USD 21 mn | 1.4% | USD 39 mn | 6.1% |
| 13 | India | USD 18 mn | 1.2% | USD 43 mn | 9.4% |
| 14 | Mexico | USD 18 mn | 1.2% | USD 35 mn | 7.3% |
| 15 | South Korea | USD 16 mn | 1.0% | USD 32 mn | 7.3% |
| 16 | Russia | USD 16 mn | 1.0% | USD 28 mn | 6.2% |
| 17 | Argentina | USD 14 mn | 0.9% | USD 25 mn | 6.2% |
| 18 | Poland | USD 14 mn | 0.9% | USD 28 mn | 7.3% |
| 19 | Thailand | USD 12 mn | 0.8% | USD 24 mn | 7.3% |
| 20 | Turkey | USD 12 mn | 0.8% | USD 26 mn | 8.4% |
| 21 | Belgium | USD 12 mn | 0.8% | USD 21 mn | 6.2% |
| 22 | Denmark | USD 12 mn | 0.8% | USD 21 mn | 6.2% |
| 23 | Switzerland | USD 9.7 mn | 0.7% | USD 18 mn | 6.2% |
| 24 | Vietnam | USD 9.7 mn | 0.7% | USD 24 mn | 9.4% |
| 25 | Ireland | USD 9.7 mn | 0.7% | USD 18 mn | 6.2% |
| Rest of world | USD 50 mn | 3.3% | USD 99 mn | 7.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- IDEXX Laboratories
- Zoetis
- Thermo Fisher Scientific
- Boehringer Ingelheim
- R-Biopharm
Group 2: Regional and specialist players
- Neogen
- IDvet
- Randox
- Bionote
- Hipra
- Ingenasa
- Biogal Galed Labs
- Bio-X Diagnostics
- LSI
Group 3: Emerging and niche players
- Heska
- Virbac
- Charm Sciences
- Tetracore
- Romer Labs
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the animal immunoassay kits market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.
The market is divided by technique, by animal, by target, by end user, by sample type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the animal immunoassay kits market?
The global animal immunoassay kits market is estimated at USD 1.4 bn in 2025 and USD 1.5 bn in 2026.
How fast will the animal immunoassay kits market grow?
It is forecast to reach USD 2.9 bn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 1.4 bn.
Which country is the largest market for animal immunoassay kits?
United States is the largest market by revenue at USD 539 mn in 2026, 36.0% of the global total. The three largest countries together hold 53.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.6% a year from 2026 to 2036.
Which animal immunoassay kits segment is largest?
In the by technique split, Rapid lateral flow and in-clinic is the largest segment with 48.0% of 2026 revenue.
Who are the leading animal immunoassay kits companies?
Global leaders include IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Boehringer Ingelheim.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Vascular Thromboembolic Disease ThrombectomyUSD 1.5 bn · 13.0% CAGR
- IsolatorUSD 1.5 bn · 8.2% CAGR
- NebulizerUSD 1.5 bn · 6.0% CAGR
- 3D Imaging Surgical SolutionUSD 1.5 bn · 8.5% CAGR
- Neurosurgery & Spine RobotsUSD 1.4 bn · 12.0% CAGR
- Muscle Stimulation DevicesUSD 1.4 bn · 5.8% CAGR
- Organ Preservation & Perfusion ProductsUSD 1.4 bn · 11.0% CAGR
- Blister MachineUSD 1.4 bn · 5.5% CAGR
← Amyotrophic Lateral Sclerosis Gene Testing Animal Wound Care →